| |DECEMBER 20244India's pharmaceutical industry has seen a year of both challenges and progress in 2024. India is the third largest global market for pharmaceuticals in terms of volume, and has remained an important player in the global healthcare ecosystem, especially in the generics and biosimilars space. The digitalization of the industry has been one of the most defining trends within the industry in 2024, and the pace of which has accelerated significantly. AI, machine learning and big data analytics are the technologies used by companies in the drug discovery, manufacturing, and distribution in an increasing measure. These innovations are not just about greater operational efficiency ­ they are also about better patient outcomes through personalized medicine and predictive analytics. India's pharmaceutical sector has been witnessing robust growth in exports spurred by a global need for low priced generic drugs, especially in emerging markets and developed countries spending billions on healthcare costs. As an effort to make the country self-reliant, government's Atmanirbhar Bharat drive is pushing investments in research and development (R&D) to ramp up domestic production of critical medicines to cut down on imports. In key areas like APIs and vaccines, this year has seen progress in particular in increasing India's manufacturing capacity. However, Indian pharma companies have had to adapt to stricter compliance and quality standards due to ongoing regulatory scrutiny from international agencies such as FDA and EMA. In addition, the cost of raw materials particularly packaging and APIs is increasing and affecting profit margins of some of the companies. Looking at the entire picture, India's pharmaceutical industry has been successful in coping with the changing face of global healthcare ecosystem and working on the lines of innovation and sustainability.Keeping tabs on this market, India Pharma Outlook has shortlisted the companies of the year that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback & suggestions. Sudhakar SinghManaging Editoreditor@indiapharmaoutlook.comStrengthening Pharma, Enriching LivesVol 2 · Issue 5 -9 · December, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerV Hari PriyaSuanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >